Company profile · federal money
Nanocan Therapeutics Corporation
Nanocan Therapeutics Corporation received $998.8K in federal awards in FY2025. Largest customer: Department of Health and Human Services ($998.8K).
- FY2025 federal obligations
- $998.8K
Largest customers: Department of Health and Human Services $998.8K
Data through 2026-09-30; source: USAspending.gov.
Gathering everything on record…
From public government records, which may contain errors. Check the official source before relying on a number. Not financial, legal or investment advice. Terms · About the data
SBIR & STTR awards
3 small-business research awards (1 Phase II) worth $1.80M, 2022–2025.
- Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical Cancer Department of Health and Human Services · STTR Phase II · $998.8K · 2025
- Radio-immunotherapy dose-painting (RAID) treatment for hormonal resistant prostate cancer Department of Health and Human Services · STTR Phase I · $399.7K · 2022
- Liquid Immunogenic Fiducial Eluter (LIFE) for Cervical Cancer Treatment Department of Health and Human Services · STTR Phase I · $400.0K · 2022
All of its SBIR & STTR awards · SBA's SBIR.gov data